LCAV, UL, AFOP, HSKA, CRDN, RGEN Are Seasonally Ripe To Go Up In the Next Five Weeks
December 19, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of LCA-VISION INC (NASDAQ:LCAV), UNILEVER PLC-SPONSORED ADR (NYSE:UL), ALLIANCE FIBER OPTIC PRODUCT (NASDAQ:AFOP), HESKA CORP (NASDAQ:HSKA), Ceradyne Inc (NASDAQ:CRDN), REPLIGEN CORP (NASDAQ:RGEN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date LCAV LCA-VISION INC 20.56% 90.91% (10 of 11) Tuesday, January 10th 2012 UL UNILEVER PLC-SPONSORED ADR 3.94% 90.63% (29 of 32) Friday, December 30th 2011 AFOP ALLIANCE FIBER OPTIC PRODUCT 10.47% 90.91% (10 of 11) Friday, December 30th 2011 HSKA HESKA CORP 25.94% 81.82% (9 of 11) Monday, January 9th 2012 CRDN Ceradyne Inc 11.97% 81.82% (9 of 11) Monday, January 9th 2012 RGEN REPLIGEN CORP 10.37% 90.91% (10 of 11) Thursday, December 29th 2011LCA-VISION INC (NASDAQ:LCAV) - LCA-Vision Inc. provides fixed-site laser vision correction services under the LasikPlus brand. The company offers laser vision correction procedures to correct nearsightedness, farsightedness, and astigmatism. As of March 31, 2010, it operated 62 LasikPlus fixed-site laser vision correction centers in the United States. The company was founded in 1985 and is headquartered in Cincinnati, Ohio.
UNILEVER PLC-SPONSORED ADR (NYSE:UL) - Unilever PLC provides fast-moving consumer goods in Asia, Africa, Europe, and Latin America. The company offers savoury, dressings, and spreads products, including soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines, spreads, as well as cooking products comprising liquid margarines and certain frozen foods under the Knorr, Hellmanns, Becel/Flora, Rama/Blue Band, Calve, Wish-Bone, Amora, Ragu, and Bertolli brands. It also provides ice creams under the Cornetto, Magnum, Carte dOr and Solero, Walls, Kibon, Algida, Ola, Ben & Jerrys, Breyers, Klondike, and Popsicle brands; tea-based beverages under the Lipton, Brooke Bond, and PG Tips brands; weight management products under the Slim Fast brand; and nutritionally enhanced products under Annapurna and AdeS brands. In addition, it provides personal care products consisting of deodorants, skin care, and hair care products under Dove, Lux, Rexona, Sunsilk, Axe/Lynx, Ponds, Suave, Clear, Lifebuoy, and Vaseline brands, as well as oral care products under Signal and Close Up brands. Further, the company offers a range of home care products comprising laundry products, such as tablets, powders, liquids, and soap bars under the Omo, Surf, Comfort, Radiant, and Skip brands; and household care products, including surface cleaners and bleach under the Cif, Domestos, and Sun/Sunlight brands. Additionally, it provides solutions for professional chefs and caterers. Unilever PLC sells its products directly, as well as through independent brokers, agents, and distributors to chain, wholesale, co-operative and independent grocery accounts, food service distributors, and institutions; and through a network of distribution centers, satellite warehouses, company-operated and public storage facilities, depots, and other facilities. The company, formerly known as Lever Brothers Limited, was founded in 1885 and is based in London, the United Kingdom. Unilever PLC is a subsidiary of The Unilever Group.
ALLIANCE FIBER OPTIC PRODUCT (NASDAQ:AFOP) - Alliance Fiber Optic Products, Inc. designs, manufactures, and markets fiber optic components and integrated modules for communications equipment manufacturers and service providers in North America, Europe, and Asia. The company offers interconnect devices that are used to connect optical fibers and components; couplers and splitters, which are used to divide and combine optical power; and dense wavelength division multiplexing, or DWDM devices that separate and combine multiple specific wavelengths. Its connectivity products include connectivity modules; optical connectors, adapters, and cable assemblies; fused and planar fiber optical splitters and couplers; optical tap couplers and ultra low polarization dependent loss tap couplers; amplifier wave divison multiplexing (WDM) couplers; optical fixed attenuators; fused fiber WDM couplers; and planar lightwave circuit splitters. Alliance Fibers optical passive products comprise filter WDMs, amplifier filter WDMs, DWDMs, coarse wavelength division multiplexers, compact coarse wavelength division multiplexers, add/drop DWDM filters, optical isolators, optical bypass switches, and automatic variable optical attenuators. The company was founded in 1995 and is headquartered in Sunnyvale, California.
HESKA CORP (NASDAQ:HSKA) - Heska Corporation engages in the development, manufacture, marketing, sale, and support of veterinary products for canine and feline companion animal health markets in the United States and internationally. The company operates in two segments, Core Companion Animal Health (CCA); and Other Vaccines, Pharmaceuticals, and Products (OVP). The CCA segment provides various veterinary diagnostic and other instruments, including The DRI-CHEM 4000, a veterinary chemistry analyzer; HEMATRUE, a veterinary hematology analyzer; and IV pumps. This segment also offers point-of-care diagnostic products comprising heartworm diagnostic products and early renal damage detection products; veterinary diagnostic laboratory products and services, such as allergy diagnostic products and services; pharmaceuticals and supplements, including heartworm prevention products, nutritional supplements, and hypothyroid treatment products. In addition, it provides vaccines and other biological products for allergy treatment and feline respiratory disease. The CCA segment markets its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors. The OVP segment provides private label vaccines and pharmaceuticals primarily for cattle, as well as for other animals, including small mammals and fish. This segment offers bovine vaccines, and biological and pharmaceutical products for other animal health companies, as well as provides turnkey services, such as research, licensing, production, labeling, and packaging of products, as well as validation support and distribution services. This segment sells its products through third parties under third party labels. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Ceradyne Inc (NASDAQ:CRDN) - Ceradyne Inc. engages in the development, manufacture, and marketing of technical ceramic products, powders, and components for defense, industrial, automotive/diesel, and commercial applications in the U.S. Its customers include the federal government, prime government contractors, and industrial, automotive, diesel, and commercial manufacturers in domestic and international markets. Ceradyne was founded in 1967 and is based in Costa Mesa, Calif.
REPLIGEN CORP (NASDAQ:RGEN) - Repligen Corporation, a biopharmaceutical company, engages in the development and commercialization of therapies that deliver value to patients and clinicians in neurology, gastroenterology, and orphan diseases. It sells a line of commercial bioprocessing products based on Protein A, as well as single or limited campaign use pre-packed chromatography columns, which are used in the production of monoclonal antibodies and other biopharmaceutical manufacturing applications. The company also offers intellectual property on monoclonal antibody and antibody fusion products consisting of CTLA4, a regulator of the activity of the immune system that provides a treatment for patients who are refractory to existing therapies, as well as certain autoimmune disorders, including rheumatoid arthritis; and Erbitux, a monoclonal antibody for the treatment of certain forms of colon cancer, as well as head and neck cancer. In addition, its development stage products include Secretin for MRI imaging of the pancreas; Uridine for bipolar depression; Histone Deacetylase Inhibitors for Friedreichs Ataxia; and DcpS Inhibitors for spinal muscular atrophy. Further, the company involves in the development and commercialization of products that are used for the production of biopharmaceuticals. It sells its products through value added resellers, as well as through distributors. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641